Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast


Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

News, archive: June 2023

6/29/2023 Pharmaceutical Drug Production in Russia (May 2023)

In January–May 2023, Russian manufacturers produced 282 billion rubles’ of pharmaceutical drugs (manufacturer’s prices, VAT included), down 5.8% from the same period in 2022. In physical terms, the production volume was 1.64 billion packages, down 9.7% from January–May 2022. If calculated in minimum dosage units (MDU), Russian manufacturers produced 32.2 billion MDUs, down 3.9% from January–May 2022.

6/19/2023 Top 20 Online Pharmaceutical Retailers in Russia in Q1 2023

In January–March 2023, the online sales or reservations of pharmacy products (pharmaceutical drugs and parapharmaceuticals) in Russia were 80.2 billion rubles (end-user prices, VAT included), up 2.3% from January–March 2022 (against 69.6% in Q1 2022, with its rush demand). This year, however, the online segment has entered a phase of stagnation due to the fact that further development might no longer be possible, when the experimental online sale of prescription drugs launched on March 1, 2023 is stalling.

6/2/2023 RNC Pharma: Top Russian Pharma Wholesaler Changed, Concentration Ratios Dropped

Russian Pharmaceutical Distributor Rankings in Q1 2023